Co-Diagnostics (CODX) Reports FY Loss of $1.20

Co-Diagnostics (NASDAQ: CODX) reported FY EPS of ($1.20). Revenue for the period came in at $6.8 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Creatd files Form S-1 and reports Q1 2026 financial results